Digital Therapeutics for ADHD: Lumosity, Meta Quest, EndeavorRx
Digital therapeutics for ADHD like Lumosity, Meta Quest, and EndeavorRx may provide new ways to manage ADHD symptoms and monitor related health conditions.
Source: additudemag.com
Revibe Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Revibe Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Revibe Technologies Today - Breaking & Trending Today
Revibe Technologies Announces Clinical Development Updates for its Investigational FokusRx Prescription Digital Therapy for the Treatment of ADHD
/PRNewswire/ -- Revibe technologies, a commercial-stage digital therapeutics company, announced today the positive results of their feasibility study examining...
Source: prnewswire.com
Revibe Technologies Announces Clinical Development Updates
– FokusRx™ feasibility study demonstrates positive results – – Company plans to initiate Phase 3 trial with FokusRx in ADHD in the second half of 2022 –...
Source: globenewswire.com
Revibe Technologies Announces Clinical Development Updates for its Investigational FokusRx Prescription Digital Therapy for the Treatment of ADHD
/PRNewswire/ -- Revibe technologies, a commercial-stage digital therapeutics company, announced today the positive results of their feasibility study examining...
Source: prnewswire.com
Revibe Technologies Promotes Chief Technical Officer, Welcomes Chief Scientific Officer and Financial Controller as Company Develops ADHD Digital Therapeutic
Revibe Technologies Promotes Chief Technical Officer, Welcomes Chief Scientific Officer and Financial Controller as Company Develops ADHD Digital Therapeutic New CSO brings substantial experience in psychological test development, Controller in accounting and auditing for the healthcare industry News provided by Share this article WAKE FOREST, N.C., April 28, 2021 /PRNewswire/ -- Revibe Technologies today announced the hiring of Dr. Lindsay Ayearst as Chief Scientific Officer, a new position created to facilitate the clinical and regulatory development of the company's upcoming state-of-the-...
Source: prnewswire.com